An undetectable viral load is necessary but not sufficient. Carriers want to see how long you have been undetectable, how consistently, and in the context of your full health profile.

What viral load is and why carriers care

Viral load measures the amount of HIV present in a milliliter of blood. It is expressed in copies per milliliter (copies/mL). When HIV is untreated, viral load can reach tens of thousands or millions of copies per milliliter. Effective antiretroviral therapy (ART) suppresses viral replication and drives the viral load down—ideally to a point where it is so low that standard tests cannot detect it.

Life insurance underwriters care about viral load because it is the most direct indicator of how well HIV is being controlled. An undetectable viral load tells the underwriter that the antiretroviral regimen is working, the virus is being prevented from replicating and damaging the immune system, and the applicant’s prognosis with continued treatment is substantially better than for someone with detectable levels.

From an underwriting perspective, viral load is the gate. It does not tell the whole story, but it is the first question. Without an undetectable viral load, traditional life insurance coverage is typically not available. With an undetectable viral load, the conversation continues.

The undetectable threshold most carriers use

Different carriers define “undetectable” differently, and the threshold matters for your application. Here is how to understand where you stand:

*Thresholds vary by carrier. These ranges reflect general industry patterns, not any specific carrier’s written guidelines.

The most HIV-friendly carriers use below 200 copies/mL as their undetectable threshold, consistent with the clinical definition. More conservative carriers require below 50 copies/mL. Know your last viral load result and which threshold applies to the carrier you are approaching.

How long you need to be undetectable

Duration of undetectable status is as important as the current reading. A single undetectable lab result is less convincing to an underwriter than a series of undetectable results over multiple years. Carriers use duration to assess the stability and reliability of viral suppression.

• 6 months undetectable: Minimum threshold at some carriers. May qualify for basic consideration, typically at higher Table ratings. Options are limited at this stage.
• 12 months undetectable: Opens more carrier options. Standard to Table C ratings become possible at HIV-friendly carriers, depending on other factors.
• 24 months undetectable: Strong position. Most HIV-friendly carriers will fully consider an application at this stage. Table A to Table B ratings are achievable.
• 36+ months undetectable: Optimal position. Best available ratings. Some carriers may offer Standard or near-Standard classification for applicants with consistently undetectable viral load over 36 months or more.

The clock starts at the first confirmed undetectable lab result after diagnosis and ART initiation. If there are gaps or blips (see below), the effective clock may reset or be complicated. Document your entire lab history carefully—it is the foundation of your application.

What a detectable viral load does to your options

If your viral load is currently detectable, traditional term or whole life underwriting is generally not available at standard carriers. This is the hardest reality of viral load and life insurance, and it is worth understanding why before exploring what options remain.

A detectable viral load signals that the current ART regimen is not fully suppressing the virus. This may mean treatment adherence issues, drug resistance, or a regimen change in progress. From a mortality risk perspective, a detectable viral load means the immune system is under active viral pressure, which correlates with higher risk of immune decline and opportunistic infections. Underwriters price this risk as too high for traditional coverage.

What remains available when viral load is detectable:

• Guaranteed issue life insurance: Accepts all applicants regardless of viral load or any health metric. Face amounts are limited ($5,000–$25,000 typically) and premiums are high per dollar of coverage, but coverage is available immediately.
• Employer group life insurance: Group coverage through work typically does not require individual health underwriting. If your employer offers group life, enrolling provides coverage without viral load screening.
• Accidental death insurance:AD&D policies often have limited or no health underwriting. They cover accidental death but not illness-related death, which significantly limits their value as life insurance, but they can provide a supplement.

If your viral load is currently detectable, the most important step is working with your HIV specialist to achieve suppression. Once you establish an undetectable viral load and maintain it for the carrier-required duration, traditional coverage becomes accessible. This is a temporary situation, not a permanent one.

Viral load blips: what they mean for underwriting

A viral load “blip” is a transient, low-level detection—typically below 200 or 400 copies/mL—that occurs between periods of undetectable results, usually returning to undetectable at the next lab draw. Blips are common and are generally not associated with virologic failure; they may reflect measurement variability or brief periods of increased viral activity that ART subsequently suppresses.

In underwriting, the significance of a blip depends on context. A single blip below 200 copies/mL in an otherwise consistently undetectable history is usually not fatal to an application at HIV-friendly carriers. It requires explanation and documentation. Multiple blips, blips above 200 copies/mL, or blips associated with treatment changes are treated more seriously.

If your lab history includes blips, your broker or underwriting submission should include documentation from your HIV specialist explaining the blip in clinical context. A physician’s letter that contextualizes a blip as transient and not indicative of virologic failure can preserve an otherwise favorable application.

How carriers verify your viral load history

Carriers do not accept self-reported viral load numbers at face value. They verify through several mechanisms:

The Attending Physician Statement (APS) is a request to your HIV specialist for your complete medical records, including all lab results on file. This is the primary source of viral load verification and will include every viral load test your specialist has on record.

A paramedical exam may include a blood draw for an in-person viral load test. For larger policies or when records are unavailable, carriers may require a current lab result obtained through their own testing protocol.

Your prescription history indirectly verifies your ART status. If you have been consistently filling ART prescriptions, it suggests consistent treatment adherence, which correlates with sustained viral suppression.

The takeaway: what your doctor has documented is what the carrier will see. Keep your lab appointments, maintain current records, and do not apply before your most recent viral load result is documented and within the past three to six months.

Improving your viral load position before applying

If your viral load is not yet where you need it to be for the best underwriting outcome, here is how to build toward it:

The most important action is consistent ART adherence. HIV medications suppress viral replication continuously. Missing doses allows the virus to replicate, which drives viral load up and increases the risk of drug resistance. Consistent daily adherence is the foundation of sustained undetectable status.

If you have been undetectable for less than 12 months, consider waiting before applying for traditional coverage. The longer your documented undetectable history, the better your underwriting outcome. Applying at 8 months undetectable when waiting until 18 months would produce a meaningfully better rate is a costly mistake.

Work with your HIV specialist to address any factors that might affect viral suppression: drug interactions with other medications, absorption issues, or signs of emerging resistance. Your HIV specialist is the right medical partner for optimizing your treatment adherence and consistency.

Common questions about viral load and coverage

Written and reviewed by Phillip Chin

Licensed Insurance Broker · NPN #8895251. Phillip is an independent broker who specializes in life insurance for people living with HIV, comparing the carriers that actually approve HIV-positive applicants.

Educational information from LifeInsuranceHIV.com, an independent brokerage. All coverage is subject to carrier underwriting and approval; eligibility, rates, and availability vary by carrier, state, and individual circumstances. Figures are estimates, not guarantees or offers of coverage.